Applied Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Applied Therapeutics, Inc. (APLT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents79.4049.9016.6680.8257.4738.85
Short-Term Investments0.000.0013.9226.9439.360.00
Cash & Short-Term Investments79.4049.9030.5880.8296.8338.85
Accounts Receivable0.000.290.280.530.510.00
Inventory0.000.000.000.000.000.00
Other Current Assets4.250.251.750.472.910.09
Total Current Assets83.6554.3937.3188.39102.5946.16
Non-Current Assets
Property, Plant & Equipment (Net)2.790.451.061.301.712.04
Other Non-Current Assets0.250.000.200.200.200.00
Total Non-Current Assets3.050.451.061.501.912.23
Total Assets86.6954.8338.3689.89104.5148.39
Current Liabilities
Accounts Payable4.431.744.539.460.648.79
Short-Term Debt0.410.310.620.790.000.00
Accrued Liabilities11.3111.8611.3512.0018.560.00
Deferred Revenue0.210.670.000.000.000.00
Other Current Liabilities22.2569.0114.1416.560.550.26
Total Current Liabilities27.3071.1833.4226.4621.249.15
Non-Current Liabilities
Long-Term Debt2.390.040.460.891.331.68
Other Non-Current Liabilities0.000.760.460.000.000.00
Total Non-Current Liabilities2.390.800.880.891.331.68
Total Liabilities29.6971.9834.3027.3522.5710.83
Stockholders' Equity
Common Stock0.040.010.010.000.000.00
Retained Earnings-574.21-468.60-348.82-266.42-160.73-66.77
Accumulated Other Comprehensive Income0.000.000.05-0.11-0.110.00
Additional Paid-in Capital631.18451.43352.83328.96242.7899.38
Shares Outstanding137.2384.8748.0626.220.000.00
Total Stockholders' Equity57.01-17.164.0662.5481.9432.61
Total Liabilities & Equity86.6954.8338.3689.89104.5148.39